CeliacShield Study
NIH-funded celiac disease research study currently enrolling eligible participants in Rochester, Minnesota.
Wish the gluten-free diet wasn’t the only protection against your celiac disease?
The CeliacShield Study is being conducted to assess the investigational drug latiglutenase and its ability to protect the small intestine of celiac disease patients from gluten exposure.
Qualifications*:
18-80 years old
Confirmed diagnosis of celiac disease
On gluten-free diet for the last 12 months
Willing to take gluten with daily evening meal for 6 weeks
Able to attend study visits at the Mayo Clinic in Rochester, MN
*Abbreviated. Other criteria apply
Compensation and reimbursement for eligible travel provided. Learn more about this exciting research and see how you can help!
ClinicalTrials.gov Study # NCT03585478